Aptinyx Completes Enrollment in Phase 2 Exploratory Study of NYX-783 in Post-Traumatic Stress Disorder EVANSTON, Ill., June 18, 2020 (GLOBE NEWSWIRE) — Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies...
Iterum Therapeutics Announces Topline Results from its Phase 3 Clinical Trial of Oral Sulopenem for the Treatment of Uncomplicated Urinary Tract Infections Sulopenem demonstrates superiority in treatment of patients with quinolone resistant pathogens Company to...
Principia Announces First Patient Enrolled in Sanofi’s Phase 3 Trial of SAR442168 in Relapsing Multiple Sclerosis Dosing of Patient Will Trigger $50 Million Milestone Payment SOUTH SAN FRANCISCO, Calif., June 23, 2020 (GLOBE NEWSWIRE) — Principia Biopharma Inc....
BrightInsight Raises $40M in Series B Funding to Cement our Position as the Leading Global Regulated Digital Health Platform for Biopharma and Medtech It’s a big day for BrightInsight. Today we announced a Series B funding round of $40M led by global venture capital...
Inspira Health Enables More Streamlined and Seamless Access to Care with Kyruus New Jersey-Based Health System is Leveraging the Kyruus Platform to Better Manage its Network and Connect Consumers to the Right Care Boston, MA – June 16, 2020 – Kyruus, the leader in...
Recent Comments